Lorianne K. Masuoka
Chief Tech/Sci/R&D Officer at DIAMEDICA THERAPEUTICS INC.
Net worth: - $ as of 29/04/2024
Lorianne K. Masuoka active positions
Companies | Position | Start | End |
---|---|---|---|
DIAMEDICA THERAPEUTICS INC. | Chief Tech/Sci/R&D Officer | 21/01/2024 | - |
Career history of Lorianne K. Masuoka
Former positions of Lorianne K. Masuoka
Companies | Position | Start | End |
---|---|---|---|
OPIANT PHARMACEUTICALS, INC. | Director/Board Member | 17/03/2021 | 01/03/2023 |
Independent Dir/Board Member | 17/03/2021 | 01/03/2023 | |
PFENEX INC. | Director/Board Member | 06/08/2019 | 30/09/2020 |
Independent Dir/Board Member | 06/08/2019 | 30/09/2020 | |
MARINUS PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 10/04/2017 | 30/10/2019 |
INVIVO THERAPEUTICS HOLDINGS CORP. | Chief Tech/Sci/R&D Officer | 28/02/2015 | 01/01/2017 |
CUBIST PHARMACEUTICALS INC | Chief Tech/Sci/R&D Officer | 07/07/2013 | 31/12/2014 |
NEKTAR THERAPEUTICS | Chief Tech/Sci/R&D Officer | 31/12/2007 | 31/12/2010 |
FIVE PRIME THERAPEUTICS, INC. | Corporate Officer/Principal | 31/12/2002 | 31/07/2008 |
Chiron Corp.
Chiron Corp. Medical SpecialtiesHealth Technology Chiron Corp. provides nucleic acid test for blood screening. Its products include tigris system, target capture system, reagent preparation incubator, and many more. The company was founded in 1981 by William J. Rutter, Edward E. Penhoet & Pablo Valenzuela and is headquartered in Emeryville, CA. | Corporate Officer/Principal | 31/12/1999 | 31/12/2002 |
░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░ ░░░░░░░░ ░░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
Training of Lorianne K. Masuoka
University of California, Davis | Doctorate Degree |
Statistics
International
United States | 12 |
Germany | 2 |
Operational
Chief Tech/Sci/R&D Officer | 5 |
Corporate Officer/Principal | 4 |
Director/Board Member | 2 |
Sectoral
Health Technology | 11 |
Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 4 |
---|---|
NEKTAR THERAPEUTICS | Health Technology |
INVIVO THERAPEUTICS HOLDINGS CORP. | Health Technology |
MARINUS PHARMACEUTICALS, INC. | Health Technology |
DIAMEDICA THERAPEUTICS INC. | Health Technology |
Private companies | 7 |
---|---|
Five Prime Therapeutics, Inc.
Five Prime Therapeutics, Inc. BiotechnologyHealth Technology Five Prime Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the discovery and development of novel protein therapeutics. Its product candidates includes, Cabiralizumab (FPA008), Bemarituzumab (FPA144), and FPA150. The FPA008 is an antibody that inhibits colony stimulating factor-1, or CSF1, receptor, or CSF1R, that are developing in rheumatoid arthritis and plan to clinically develop in pigmented villonodular synovitis, or PVNS, and in combination with nivolumab in multiple cancers. The FPA144 is an antibody that inhibits fibroblast growth factor receptor 2b, or FGFR2b, that are developing to treat patients with gastric cancer. The FPA150 is a CD8 T cell checkpoint which targets B7-H4 that is developing as a monotherapy in multiple cancers. The company was founded by Lewis T. Williams in December 2001 and is headquartered in South San Francisco, C. | Health Technology |
Chiron Corp.
Chiron Corp. Medical SpecialtiesHealth Technology Chiron Corp. provides nucleic acid test for blood screening. Its products include tigris system, target capture system, reagent preparation incubator, and many more. The company was founded in 1981 by William J. Rutter, Edward E. Penhoet & Pablo Valenzuela and is headquartered in Emeryville, CA. | Health Technology |
Cubist Pharmaceuticals LLC
Cubist Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Cubist Pharmaceuticals LLC operates as a biopharmaceutical company. It focuses on the research, development and commercialization of pharmaceutical products. The company was founded in 1992 and is headquartered in Lexington, MA. | Health Technology |
Berlex Laboratories, Inc. | |
Pelican Inc
Pelican Inc BiotechnologyHealth Technology Pfenex, Inc. is a development and licensing Biotechnology Company, which focuses on leveraging its Pfenex Expression Technology platform for developing and improving protein therapies. Its products include PF708, PF743, PF745, CRM197, PF810, PF753 and PFXX. The company was founded on November 19, 2009 and is headquartered in San Diego, CA. | Health Technology |
Bayer Schering Pharma AG | Health Technology |
Opiant Pharmaceuticals, Inc.
Opiant Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Opiant Pharmaceuticals, Inc. is a pharmaceutical company, which engages in the development of pharmaceutical solutions for common addictions and related disorders. The firm focuses on developing treatment to reverse opioid overdoses, treatment for overweight and obese patients with binge eating disorder and treatment for patients with Bulimia Nervosa. Its principal product Naloxone is a medicine which is available through injection can reverse the overdose of prescription and illicit opioids. The company was founded on June 21, 2005 and is headquartered in Richmond, VA. | Health Technology |
- Stock Market
- Insiders
- Lorianne K. Masuoka
- Experience